Clinical research depicting pharmaceutical drug discovery and development

Academic-led pharma company secures £180m funding boost to translate research into medicines

A university-led biopharmaceutical company has secured almost £200m in funding to translate promising medical research into actual medicines.

The £180m investment has gone into Apollo Therapeutics, an organisation originally set up by six partners:

June 2021 saw the partnership become an independent pharmaceutical company after a £115m raise but all the founding members still remain, with King’s College London and the Institute of Cancer Research also both recently joining.

                                                                      Video credit: Canva

The funding will be used to license or acquire additional clinical stage programmes.

“This is a fantastic achievement, from a great team and great investors capitalising on a unique effective drug discovery and development model,” said Dr Iain Thomas, the head of life sciences at Cambridge Enterprise, which is the arm of Cambridge University responsible for translating research into economic and social impact.

Apollo has a scalable research and development platform for the discovery of new medicines; it selects programmes on the quality of the science and the potential to benefit the standard of patient care.

Dr Thomas added: “We are so proud to have been founders with great colleagues at Imperial College and UCL with our pharma partners AstraZeneca, GSK and Johnson and Johnson to deliver patient benefit from ground-breaking academic science.”

Image credit: iStock

Website cover

NHE May/June 2024

Join the conversation shaping the future of healthcare.

Click below to read more!

More articles...

View all
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Listen to industry leaders on everything within healthcare

Whether it's the latest advancements in medical technology, healthcare policies, patient care innovations, or the challenges facing healthcare providers, we cover it all.

 

Join us as we engage with top healthcare professionals, industry leaders, and policy experts to bring you insightful conversations that matter.